logo
Why Europe Needs A sovereign Cloud In The AI Race

Why Europe Needs A sovereign Cloud In The AI Race

Forbes15-05-2025

BRUSSELS, BELGIUM - APRIL 5 : Flags from the 27 countries of the EU flies in the wind in front of ... More the European Parliament on April 5, 2025 in Brussels, Belgium. (Photo by)
The AI war is on the horizon. The announcements from the United States and China at Davos, followed by Europe's response at the Paris AI Action Summit, attest to that. As with the outset of any conflict, it is instructive to take stock of the forces at play.
The United States leads the pack, largely thanks to its investment firepower. By mid-April, the combined market capitalisation of U.S. tech companies had reached $35 trillion, and cumulative investments in generative AI-focused firms were approaching $90 billion. Those figures are respectively five and fourteen times higher than China's, and eighteen and twenty-two times greater than Europe's. The U.S. also exerts immense pull on human capital, with 60 % of the world's top AI talent residing there. It commands the largest data-centre capacity globally and has secured access to the latest generation microprocessors. Consequently, 59 % of the world's 'significant' LLMs (Large Language Models) originate from the United States.
U.S. Funding and Chinese Patents
China, for its part, pours massive resources into public research and counts 45 of the world's top 100 academic institutions in AI. Between 2019 and 2023, these centres produced 76,000 patents – four times as many as the United States and twenty times more than Europe. Their teams benefit from a uniquely rich data ecosystem in a nation where both state bodies and households are among the most digitised worldwide.
Europe occupies the third spot on the podium, ahead of other AI contenders such as India, the Middle East and Singapore. This continent also ranks third in data-centre capacity, size of its AI specialist pool, production of 'significant' models and number of research papers published.
The anticipated developments in AI are unequivocal: access to computing power and mastery of data-management platforms will be decisive factors in both competitiveness and sovereignty. As one the leading European CEOs put it, 'When I have the choice between Amazon, Google or Microsoft, I'm not entirely at ease.'
Brussels: Plenty of Regulations, Few Champions
The European Commission has taken the lead in drafting an AI Cloud and Development Act, the regulatory pillar of its 'AI Continent' action plan. Legislation matters, but Europe will truly earn its place only if one or two world-class European cloud champions emerge. In France, economic decision-makers have already marshalled support to elevate Mistral from a national rising star to a global unicorn, so why not?
'Access to computing power and mastery of data management platforms will be key factors in both competitiveness and sovereignty.'
To succeed in the sovereign cloud arena, Europe must exorcise its old demons. First, it needs a single, pragmatic regulatory framework untainted by national riders that fragment the market and deny operators the full benefits of scale. Next, it must abandon the idea of one provider per country or, worse, a single 'UN style' player whose governance is paralysed by representation from dozens of member states. Finally, with mergers likely on the horizon, Europe should recognise that the emergence of continental champions need not imperil consumers, in fact, it can help protect them.
Some welcomed Europe's April sanctions on Apple (€500 million) and Meta (€200 million) for flouting the Digital Markets Act (DMA)… but without homegrown champions, those penalties risk feeling like a Pyrrhic victory, their costly triumph having sounded the death knell of its own empire.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Amazon, Cameco, Universal Health Services: Trending Tickers
Amazon, Cameco, Universal Health Services: Trending Tickers

Yahoo

time18 minutes ago

  • Yahoo

Amazon, Cameco, Universal Health Services: Trending Tickers

Amazon (AMZN) is investing $20 billion in Pennsylvania data centers as Big Tech companies work to expand artificial intelligence (AI) infrastructure. Cameco (CCJ) stock surges after Westinghouse Electric Corporation, a company of which Cameco owns a significant portion, increased its EBITDA outlook for the next year and signed a nuclear deal. Universal Health Services (UHS) stock is falling after the company's CFO, Steve Filton, said that patients are spending longer in the hospital than they did pre-COVID. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. Sign in to access your portfolio

Warner Bros. Discovery Stock Enjoys Big Jump, Then Promptly Fades After Split Announcement
Warner Bros. Discovery Stock Enjoys Big Jump, Then Promptly Fades After Split Announcement

Yahoo

time18 minutes ago

  • Yahoo

Warner Bros. Discovery Stock Enjoys Big Jump, Then Promptly Fades After Split Announcement

Warner Bros. Discovery's plan to split into two publicly traded companies sent its stock price surging higher on Monday morning, with shares of WBD jumping 13% to $11.10 on the Nasdaq exchange only minutes after the opening bell. Those early gains started to fade by midday, though, with Warner Bros. Discovery's stock trading for $9.94 per share at 1 p.m. ET — up 1.30% from where it closed last week. Here is an up-to-the-minute look at WBD: On the year, WBD is down 6%, and the company's stock price has been more than sliced in half since it debuted on the Nasdaq in 2022 for $24.08 per share. That came after WarnerMedia and Discovery merged — a move that was met with a collective shrug from Wall Street analysts and investors from the start, with its stock price increasing 0.8% on April 11, 2022, its first day of trading. Now, three years later, WBD announced on Monday it will split into two companies, with one company focused on its global cable channels and another dedicated to its movie and streaming businesses. David Zaslav, president and CEO of WBD, will become president and CEO of Streaming & Studios, while Gunnar Wiedenfels, WBD's CFO, will serve as president and CEO of Global Networks. The separation is expected to be completed by mid-2026. 'By operating as two distinct and optimized companies in the future, we are empowering these iconic brands with the sharper focus and strategic flexibility they need to compete most effectively in today's evolving media landscape,' Zaslav said in a statement. The new Streaming & Studios operation will consist of Warner Bros. Television, Warner Bros. Motion Picture Group, DC Studios, HBO and HBO Max, in addition to their corresponding film and television libraries. Global Networks, meanwhile, will include international entertainment, sports and TV news brands such as CNN, TNT Sports, Discovery, Discovery+, Bleacher Report and European free-to-air channels. In related news, WBD investors last week voted to reject a $51.9 million compensation package for Zaslav. The post Warner Bros. Discovery Stock Enjoys Big Jump, Then Promptly Fades After Split Announcement appeared first on TheWrap. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

No drug price pledges in talks with US government, Pfizer CEO says
No drug price pledges in talks with US government, Pfizer CEO says

Yahoo

time19 minutes ago

  • Yahoo

No drug price pledges in talks with US government, Pfizer CEO says

STORY: Pfizer CEO Albert Bourla said Monday that he and other drug companies met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made. He made the comments at a Goldman Sachs healthcare conference. Last month President Trump issued an executive order directing drugmakers to lower the prices of their medicines to align with what other countries pay. According to the order, the administration was to set "Most Favored Nation" price targets within 30 days. The Department of Health and Human Services has said it expects drugmakers in the U.S. to set prices for their products at the lowest price paid by other high-income countries. Bourla said he didn't know what the companies would hear in 30 days and added the meetings with the administration so far were cordial but (quote) "not digging into the substance." It is unclear what mechanism the U.S. government will use to lower drug prices - analysts and legal experts have said the policy will be difficult to implement. Bourla said he is hopeful that, given U.S. pressure on European countries to pay more, prices there could increase. He said that if the U.S. resorts to price controls, Pfizer could consider not making drugs available for government reimbursement in some countries if prices don't increase there. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store